MedPath
FDA Approval

Kyleena

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
March 13, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levonorgestrel(19.5 mg in 1 1)

Manufacturing Establishments4

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bayer Schering Pharma Oy

Bayer HealthCare Pharmaceuticals Inc.

369758383

Sharp Corporation

Bayer HealthCare Pharmaceuticals Inc.

143696495

Bayer AG

Bayer HealthCare Pharmaceuticals Inc.

342872971

Sterigenics Belgium Petit-Rechain S.A.

Bayer HealthCare Pharmaceuticals Inc.

370026481

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Kyleena

Product Details

NDC Product Code
50419-424
Application Number
NDA208224
Marketing Category
NDA (C73594)
Route of Administration
INTRAUTERINE
Effective Date
March 1, 2018
Code: 5W7SIA7YZWClass: ACTIBQuantity: 19.5 mg in 1 1
DIMETHICONEInactive
Code: 92RU3N3Y1OClass: IACT
BARIUM SULFATEInactive
Code: 25BB7EKE2EClass: IACT
© Copyright 2025. All Rights Reserved by MedPath